O
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules. Combining advanced cell engineering, high-throughput chemistry, and automation we are engineering best-in-class drugs across rare disease, oncology, and immunology.
Investor insights
Funding rounds participated in
$80M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2017
Funding rounds raised
Total raised
$80M
from 2 investors over 1 rounds
O
Octant raised $80M on May 28, 2022
Investors: Catalio Capital Management and + 6 Other investors